Srinath Kashi Ranganath is a Staff Scientist in Pharma Analytics at Thermo Fisher Scientific, where he enables biopharmaceutical organizations to advance biologics, cell and gene therapies, and next-generation therapeutics through robust analytical solutions. He supports customers from early evaluation through implementation and validation, ensuring alignment with regulatory and pharmacopeial expectations.
With over a decade of experience spanning research and GMP-regulated environments, Srinath specializes in qPCR-based methods, residual impurity testing, and cell-based assays. He has deep expertise in assay development, validation, and lifecycle support, helping translate complex analytical challenges into scalable, compliant workflows across diverse therapeutic modalities.
Srinath collaborates cross-functionally with R&D, quality, and manufacturing teams, contributes to new product introductions, and frequently presents at industry conferences and technical forums on bioprocess analytics and emerging technologies. He previously worked in analytical development and quality control at Fujifilm Diosynth Biotechnologies.
He holds graduate degrees in Pharmaceutical Sciences and Management and has authored multiple scientific publications.